Scarica l'app Stockscreener
65.46
2.98%
-2.01
Dopo l'orario di chiusura:
65.69
0.23
+0.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GH Giù?
Forum
Previsione
Guardant Health Inc Borsa (GH) Ultime notizie
Why Guardant Health Inc. stock is recommended by analystsRisk Management & Free Expert Verified Stock Movement Alerts - newser.com
Is Guardant Health Inc. building a consolidation baseQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com
Guardant Health stock hits 52-week high at 68.01 USD - Investing.com
Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025 - 01net
Guardant Health And Collaborators To Present New Data Across The Cancer Care Continuum At Esmo 2025 - TradingView
What institutional flow reveals about Guardant Health Inc.July 2025 WrapUp & Daily Volume Surge Signals - newser.com
How to use Fibonacci retracement on Guardant Health Inc.July 2025 Opening Moves & Safe Entry Point Alerts - newser.com
Guardant Health files lawsuit against Natera for stealing trade secrets - MSN
How to track smart money flows in Guardant Health Inc.Stock Surge & Free Technical Confirmation Trade Alerts - newser.com
Can Guardant Health Inc. stock deliver consistent earnings growthTrade Entry Summary & High Accuracy Trade Alerts - newser.com
Guardant Health: Hold Rating Ahead Of Q3 Results On Valuation And Execution Risk (GH) - Seeking Alpha
Guardant Health, Inc. (GH) Stock Analysis: A Growth Powerhouse with a 6.81% Upside Potential - DirectorsTalk Interviews
What analysts say about Guardant Health Inc stockRisk-Reward Ratio Analysis & Best Stocks For Explosive Growth - earlytimes.in
Guardant Health, Inc. (NASDAQ:GH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Using Ichimoku Cloud for Guardant Health Inc. technicals2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025 - FinancialContent
CustomerThink - CustomerThink
Quantitative breakdown of Guardant Health Inc. recent movePortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
Why Guardant Health Inc. (5GH) stock stays on top picksOptions Play & AI Powered Market Entry Strategies - newser.com
Pattern recognition hints at Guardant Health Inc. upsideTake Profit & Weekly High Conviction Trade Ideas - newser.com
Abel Hall LLC Invests $202,000 in Guardant Health, Inc. $GH - MarketBeat
Published on: 2025-10-09 03:21:22 - newser.com
Guardant Health's (GH) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
What drives Guardant Health Inc 5GH stock priceAnalyst Downgrades & Market Volatility Strategies - earlytimes.in
Evercore ISI Group Raises Price Target for Guardant Health (GH) to $68 | GH Stock News - GuruFocus
Evercore ISI Raises Guardant Health (NASDAQ:GH) Price Target to $68.00 - MarketBeat
Liquid Biopsy for Early Cancer Detection and Monitoring - GlobeNewswire
Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and Oncimmune - Yahoo Finance
Is Guardant Health Inc. (5GH) stock dividend growth reliableTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Visualizing Guardant Health Inc. stock with heatmapsCPI Data & Weekly Return Optimization Plans - newser.com
What momentum shifts mean for Guardant Health Inc.Quarterly Market Review & Precise Trade Entry Recommendations - newser.com
Using economic indicators to assess Guardant Health Inc. potentialJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Guardant Health Inc Stock Analysis and ForecastMarket Liquidity Analysis & Rapid Capital Trading Plans - earlytimes.in
Shareholders in Guardant Health (NASDAQ:GH) Are in the Red If They Invested Three Years Ago - 富途牛牛
Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic - MSN
How FDA Approval of Guardant360 CDx as Companion Diagnostic Could Impact Guardant Health (GH) Investors - Yahoo Finance
Is Quest Diagnostics' (DGX) Shield Partnership Transforming Its Role in Preventive Health Innovation? - Yahoo Finance
How to use a screener to detect Guardant Health Inc. breakoutsTrade Risk Report & Smart Money Movement Alerts - newser.com
Comparing Guardant Health Inc. in custom built stock radarsJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Risk adjusted return profile for Guardant Health Inc. analyzedMarket Sentiment Report & Daily Momentum Trading Reports - newser.com
Barclays Raises Price Target for Guardant Health (GH) to $70.00 | GH Stock News - GuruFocus
4,782 Shares in Guardant Health, Inc. $GH Purchased by Trivium Point Advisory LLC - MarketBeat
GCC Liquid Biopsy Market Forecast and Company Analysis - GlobeNewswire
GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex - Yahoo Finance
Sicart Associates LLC Increases Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (GH) Unveils Shield V2, Boosts Early Cancer Detection Accuracy - Insider Monkey
What drives Guardant Health Inc stock priceEx-Dividend Date Alerts & Free Take Advantage Of Momentum - earlytimes.in
Stocks making big moves yesterday: Beyond Meat, The Trade Desk, Guardant Health, PayPal, and Tilray - The Globe and Mail
0.08%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):